Literature DB >> 7802445

[Usefulness of 5-FU high-dose continuous therapy at home in patients with recurrent gastric and colon cancer].

K Kawano1, T Inokuchi, T Fujihara, F Mori, Y Yoshioka, Y Tamura, K Kimoto.   

Abstract

Recurrence of gastric cancer or colon cancer was observed in some patients who received 5-fluorouracil (5-FU) high-dose continuous Methotrexate (MTX)-Leucovorin (LV) therapy (FML therapy) previously. 5-FU high-dose 48-hours continuous therapy (5-FU therapy) as maintenance therapy for the patients was performed in the hospital and successively at home. The patients included 3 with recurrent gastric cancer and 2 with recurrent colon cancer: there were 4 males and 1 female, the mean age was 51.8 years (33-59 years). All patients had received FML therapy during the hospital stay before the maintenance chemotherapy at home. 5-FU therapy (30 mg/kg/day x 2 days/w), 30.2 courses on an average (11-40 courses), was performed through a catheter (Port-A-Cath), which was introduced into the right subclavian vein and placed under the skin, with a Baxter infusion pump. The concentration of 5-FU was 197 +/- 172-401 +/- 127 ng/ml between the 2nd and 48th hour. Adverse reaction included anorexia in 5 patients, stomatitis in 4, pigmentation in 4, leukopenia in 3, neuropathy in 2 and alopecia in 1. The therapy was effective for 10.4 months on an average (4-18 months) and the mean survival period was 12.0 months (7-18 months).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7802445

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  1 in total

1.  Safety of chronic low-dose capecitabine as maintenance therapy in gastrointestinal cancers.

Authors:  Jun F Sun; Rebekah R Wu; Craig Norris; Anne-Michelle Noone; Margaret Amankwa-Sakyi; Rebecca Slack; John L Marshall
Journal:  Gastrointest Cancer Res       Date:  2009-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.